No phaseNot yet recruitingAge-related condition

Undenatured Type II Collagen for Knee Osteoarthritis Pain (FLEXICOL)

Randomized Clinical Trial to Analyze the Efficacy and Safety of Undenatured Type II Collagen Product on Joint Pain in Patients Diagnosed With Osteoarthritis

Sponsor
Universidad Católica San Antonio de Murcia (Academic or other)
Enrolment
120 planned
Conditions
Osteoarthritis, Knee
Interventions
Placebo; Nuvicol II; Nuvicol SII
Ages
adults, older adults
Registry
NCT07870967

Full record on ClinicalTrials.gov

From the registry

This randomized, controlled, double-blind, three-arm parallel clinical trial will evaluate the efficacy and safety of undenatured type II collagen products on joint pain in adults diagnosed with knee osteoarthritis. Participants will be randomized to Nuvicol II, Nuvicol SII, or placebo and will consume one capsule daily for 4 months. Pain, quality of life, knee muscle function, concomitant analgesic medication use, cartilage degradation biomarkers, safety laboratory variables, and adverse events will be assessed during follow-up.

Primary outcomes

  • Change in joint pain intensity measured by visual analog scale

History

  1. Primary completion expected

  2. Expected to start

  3. Last registry update

  4. Registered